國家衛生研究院 NHRI:Item 3990099045/4672
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 909876      線上人數 : 835
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4672


    題名: Adaptation of influenza H5N1 vaccine viruses in vero cells
    作者: Tseng, YF;Weng, TC;Chen, YS;Hu, AYC;Chong, P;Lee, MS
    貢獻者: Vaccine Research and Development Center
    摘要: Current egg-based influenza vaccine production technology is labor-intensive and lack of flexibility and its capacity would not be able to meet the demand during influenza pandemics. Therefore, vaccine production using mammalian cell technology is becoming viable and attractive. The current influenza H5N1 vaccine strain (NIBRG-14) could grow efficiently in chicken embroyonated eggs and MDCK cells ( ∼ 10 8 TCID50/ml) but not in Vero cells (10 5—6 TCID50/ml) which is the most common cell line for manufacturing human vaccines. After several passages and plaque purifications, two Vero-adapted high growth influenza H5N1 vaccine viruses (Vero-15 and Vero-16) have been selected and could reach high virus titer (10 8 TCID50/ml) in Vero cells in T flasks. After tested with NIBRG-14 standard antiserum provided by the NIBSC, antigenicity of the Vero-15 and Vero-16 viruses remain similar to the NIBRG-14 virus. In addition, the Vero-15 and Vero-16 viruses do not have any nucleotide difference in HA and NA gene segments compared with the NIBRG-14. For process development, Vero cells were furture cultured on cytodex 1 microcarriers in spinner flasks. Vero cells growed to 3 × 10 6 cells/ml with a seeding density of 4.4 × 10 5 cells/ml in 5 g/L microcarriers and peak virus titers reached 10 9 TCID50/ml. In conclusion, the Vero-15 and Vero-16 viruses are suitable for production of influenza H5N1 vaccines in Vero cells. Their other six internal gene segments could also be used to generate vaccine seed viruses of other influenza subtypes for production in Vero cells.
    日期: 2008-12
    關聯: International Journal of Infectious Diseases. 2008 Dec;12(Suppl. 1):E253-E254.
    Link to: http://dx.doi.org/10.1016/j.ijid.2008.05.687
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1201-9712&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000263287800633
    顯示於類別:[李敏西] 會議論文/會議摘要
    [莊再成] 會議論文/會議摘要
    [胡勇誌] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000263287800633.pdf67KbAdobe PDF686檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋